β Oscillation During Slow Wave Sleep and Rapid Eye Movement Sleep in the Electroencephalogram of a Transgenic Mouse Model of Huntington's Disease

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Nov 19

PMID 24244517

Citations 11

Authors

Yannick Jeantet

Sebastien Cayzac

Yoon H Cho

Affiliations

Soon will be listed here.

Abstract

Study Objectives: To search for early abnormalities in electroencephalogram (EEG) during sleep which may precede motor symptoms in a transgenic mouse model of hereditary neurodegenerative Huntington's disease (HD).

Design: In the R6/1 transgenic mouse model of HD, rhythmic brain activity in EEG recordings was monitored longitudinally and across vigilance states through the onset and progression of disease.

Measurements And Results: Mice with chronic electrode implants were recorded monthly over wake-sleep cycles (4 hours), beginning at 9-11 weeks (presymptomatic period) through 6-7 months (symptomatic period). Recording data revealed a unique β rhythm (20-35 Hz), present only in R6/1 transgenic mice, which evolves in close parallel with the disease. In addition, there was an unusual relationship between this β oscillation and vigilance states: while nearly absent during the active waking state, the β oscillation appeared with drowsiness and during slow wave sleep (SWS) and, interestingly, strengthened rather than dissipating when the brain returned to an activated state during rapid eye movement (REM) sleep.

Conclusions: In addition to providing a new in vivo biomarker and insight into Huntington's disease pathophysiology, this serendipitous observation opens a window onto the rarely explored neurophysiology of the cortico-basal ganglia circuit during SWS and REM sleep.

Citing Articles

Open-Source Algorithm for Automated Vigilance State Classification Using Single-Channel Electroencephalogram in Rodents.

Saevskiy A, Suntsova N, Kosenko P, Alam M, Kostin A Sensors (Basel). 2025; 25(3).

PMID: 39943560 PMC: 11820057. DOI: 10.3390/s25030921.

Sleep and Circadian Rhythm Dysfunction in Animal Models of Huntington's Disease.

Morton A J Huntingtons Dis. 2023; 12(2):133-148.

PMID: 37334613 PMC: 10473141. DOI: 10.3233/JHD-230574.

Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3.

Tsimpanouli M, Ghimire A, Barget A, Weston R, Paulson H, Costa M Cells. 2022; 11(19).

PMID: 36231095 PMC: 9563426. DOI: 10.3390/cells11193132.

Orexinergic System in Neurodegenerative Diseases.

Wang Q, Cao F, Wu Y Front Aging Neurosci. 2021; 13:713201.

PMID: 34483883 PMC: 8416170. DOI: 10.3389/fnagi.2021.713201.

Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease.

Cabanas M, Pistono C, Puygrenier L, Rakesh D, Jeantet Y, Garret M Neurotherapeutics. 2019; 16(3):784-796.

PMID: 30915710 PMC: 6694444. DOI: 10.1007/s13311-019-00726-3.

References

Cayzac S, Delcasso S, Paz V, Jeantet Y, Cho Y . Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease. Proc Natl Acad Sci U S A. 2011; 108(22):9280-5. PMC: 3107308. DOI: 10.1073/pnas.1016190108. View

Urrestarazu E, Iriarte J, Alegre M, Clavero P, Rodriguez-Oroz M, Guridi J . Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease. Mov Disord. 2008; 24(2):254-60. DOI: 10.1002/mds.22351. View

Morton A, Wood N, Hastings M, Hurelbrink C, Barker R, Maywood E . Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci. 2005; 25(1):157-63. PMC: 6725210. DOI: 10.1523/JNEUROSCI.3842-04.2005. View

Snowden J, Craufurd D, Thompson J, Neary D . Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol. 2002; 24(2):133-45. DOI: 10.1076/jcen.24.2.133.998. View

GERBRANDT L, Lawrence J, Eckardt M, Lloyd R . Origin of the neocortically monitored theta rhythm in the curarized rat. Electroencephalogr Clin Neurophysiol. 1978; 45(4):454-67. DOI: 10.1016/0013-4694(78)90290-0. View

Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C . Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996; 87(3):493-506. DOI: 10.1016/s0092-8674(00)81369-0. View

Ermis U, Krakow K, Voss U . Arousal thresholds during human tonic and phasic REM sleep. J Sleep Res. 2010; 19(3):400-6. DOI: 10.1111/j.1365-2869.2010.00831.x. View

Naver B, Stub C, Moller M, Fenger K, Hansen A, Hasholt L . Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse. Neuroscience. 2003; 122(4):1049-57. DOI: 10.1016/j.neuroscience.2003.08.053. View

Degos B, Deniau J, Chavez M, Maurice N . Chronic but not acute dopaminergic transmission interruption promotes a progressive increase in cortical beta frequency synchronization: relationships to vigilance state and akinesia. Cereb Cortex. 2008; 19(7):1616-30. DOI: 10.1093/cercor/bhn199. View

10.

Wiegand M, Moller A, Lauer C, Stolz S, Schreiber W, Dose M . Nocturnal sleep in Huntington's disease. J Neurol. 1991; 238(4):203-8. DOI: 10.1007/BF00314781. View

11.

Brown P . Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord. 2003; 18(4):357-63. DOI: 10.1002/mds.10358. View

12.

Vonsattel J, Myers R, Stevens T, Ferrante R, BIRD E, Richardson Jr E . Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985; 44(6):559-77. DOI: 10.1097/00005072-198511000-00003. View

13.

Pang T, Stam N, Nithianantharajah J, Howard M, Hannan A . Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience. 2006; 141(2):569-584. DOI: 10.1016/j.neuroscience.2006.04.013. View

14.

Petersen A, Gil J, Maat-Schieman M, Bjorkqvist M, Tanila H, Araujo I . Orexin loss in Huntington's disease. Hum Mol Genet. 2004; 14(1):39-47. DOI: 10.1093/hmg/ddi004. View

15.

Wiegand M, Moller A, Schreiber W, Lauer C, Krieg J . Brain morphology and sleep EEG in patients with Huntington's disease. Eur Arch Psychiatry Clin Neurosci. 1991; 240(3):148-52. DOI: 10.1007/BF02190755. View

16.

Silverman D . Sleep as a general activation procedure in electroencephalography. Electroencephalogr Clin Neurophysiol. 1956; 8(2):317-24. DOI: 10.1016/0013-4694(56)90123-7. View

17.

Jeantet Y, Cho Y . Design of a twin tetrode microdrive and headstage for hippocampal single unit recordings in behaving mice. J Neurosci Methods. 2003; 129(2):129-34. DOI: 10.1016/s0165-0270(03)00172-9. View

18.

Spires T, Grote H, Varshney N, Cordery P, Dellen A, Blakemore C . Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci. 2004; 24(9):2270-6. PMC: 6730435. DOI: 10.1523/JNEUROSCI.1658-03.2004. View

19.

Nithianantharajah J, Barkus C, Murphy M, Hannan A . Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis. 2008; 29(3):490-504. DOI: 10.1016/j.nbd.2007.11.006. View

20.

Steriade M . Corticothalamic resonance, states of vigilance and mentation. Neuroscience. 2000; 101(2):243-76. DOI: 10.1016/s0306-4522(00)00353-5. View